Literature DB >> 16520203

Clinical and radiographic assessment of a modular cementless ingrowth femoral stem system for revision hip arthroplasty.

William L Walter1, William K Walter, Bernard Zicat.   

Abstract

This article presents 6-year mean (2-12-year) clinical and radiographic follow-up of 62 proximally porous-coated modular S-ROM femoral revisions. These patients come from 106 consecutive cases in 97 patients performed by one surgeon between 1987 and 1992 without structural allograft (femoral bone loss was Paprosky types 1-3B). In the 99 cases with known outcome, there were 7 postoperative complications: 2 dislocations (2%), 2 deep infections (2%), 2 periprosthetic femoral fractures (2%), and 1 transient sciatic nerve palsy (1%). There was only 1 revision of the index surgery for a problem related to the stem (dislocation). Of the 62 stems, 59 (95%) with complete follow-up were ingrown, 2 (3%) were loose, and 1 had stable fibrous fixation. This represents a mechanical failure rate of 5%. Stems greater than 16 mm in diameter were more likely to show stress shielding (P = .009) and not to be ingrown (P = .0006).

Entities:  

Mesh:

Year:  2006        PMID: 16520203     DOI: 10.1016/j.arth.2005.03.044

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  [Modular noncemented femoral stem system in revision total hip arthroplasty].

Authors:  M D Schofer; T Efe; T J Heyse; N Timmesfeld; R Velte; F Hinrichs; J Schmitt
Journal:  Orthopade       Date:  2010-02       Impact factor: 1.087

2.  Medium-term outcomes of the S-ROM modular femoral stem in revision hip replacement.

Authors:  Jesús Moreta; Iker Uriarte; Xabier Foruria; Ane Loroño; Urko Agirre; Iñaki Jáuregui; José Luis Martínez-de Los Mozos
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-04-25

3.  High medium-term survival of Zweymüller SLR-plus stem used in femoral revision.

Authors:  Panagiotis Korovessis; Thomas Repantis
Journal:  Clin Orthop Relat Res       Date:  2009-03-03       Impact factor: 4.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.